Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.930
+0.030 (1.58%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Bluejay Diagnostics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | - | - | - | 0.25 | - | |
| Cost of Revenue | - | - | - | 0.2 | - | |
| Gross Profit | - | - | - | 0.05 | - | |
| Selling, General & Admin | 3.91 | 3.7 | 4.6 | 5.21 | 2.08 | |
| Research & Development | 3.01 | 3.47 | 5.71 | 4.15 | 1.15 | |
| Operating Expenses | 6.92 | 7.17 | 10.31 | 9.37 | 3.23 | |
| Operating Income | -6.92 | -7.17 | -10.31 | -9.32 | -3.23 | |
| Interest Expense | -0 | -0.82 | - | - | -0.51 | |
| Interest & Investment Income | 0.1 | 0.15 | 0.16 | 0.09 | - | |
| Other Non Operating Income (Expenses) | 0.01 | 0.13 | 0.19 | 0.17 | 0.25 | |
| EBT Excluding Unusual Items | -6.81 | -7.72 | -9.95 | -9.06 | -3.49 | |
| Asset Writedown | -0.04 | - | - | -0.24 | - | |
| Other Unusual Items | - | - | - | - | 0.01 | |
| Pretax Income | -6.85 | -7.72 | -9.95 | -9.3 | -3.49 | |
| Net Income | -6.85 | -7.72 | -9.95 | -9.3 | -3.49 | |
| Preferred Dividends & Other Adjustments | - | 13.22 | - | - | - | |
| Net Income to Common | -6.85 | -20.94 | -9.95 | -9.3 | -3.49 | |
| Shares Outstanding (Basic) | 0 | 0 | - | - | - | |
| Shares Outstanding (Diluted) | 0 | 0 | - | - | - | |
| Shares Change (YoY) | 879.42% | - | - | - | - | |
| EPS (Basic) | -15.25 | -456.75 | - | - | - | |
| EPS (Diluted) | -15.25 | -456.75 | - | - | - | |
| Free Cash Flow | -6.23 | -8.13 | -9.02 | -8.94 | -4.39 | |
| Free Cash Flow Per Share | -13.87 | -177.27 | - | - | - | |
| Gross Margin | - | - | - | 19.64% | - | |
| Operating Margin | - | - | - | -3741.48% | - | |
| Profit Margin | - | - | - | -3733.11% | - | |
| Free Cash Flow Margin | - | - | - | -3590.13% | - | |
| EBITDA | -6.84 | -7.09 | -9.66 | -9.16 | -3.08 | |
| D&A For EBITDA | 0.07 | 0.08 | 0.65 | 0.16 | 0.15 | |
| EBIT | -6.92 | -7.17 | -10.31 | -9.32 | -3.23 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.